Skip Navigation
Return to All Schools

Raj and Kamla Gupta Professorship in Infectious Diseases

School of Medicine

Established in 2018 to support Dr. Robert C. Bollinger's research as Director of the Center for Clinical Global Health Education

RAJ L. GUPTA has served as Chairman of APTIV PLC since March 2015 (formerly Delphi Automotive PLC). From 1999 – 2009, Mr. Gupta was Chairman and Chief Executive Officer of Rohm and Haas and held a variety of posts at the company beginning in 1971. He was elected a vice president of the company and was named director for the Pacific Region in 1993. Early in 1996, Mr. Gupta became one of six members of the Chairman’s Committee and was given oversight responsibility for the company’s Electronic Materials business group. In December 1998, Mr. Gupta was elected to the Board of Directors and named Vice Chairman in January 1999. He became Chairman and Chief Executive Officer on October 1, 1999. Mr. Gupta assumed the additional title of President in early 2005 and held that title until May 2008.

Mr. Gupta holds a BS degree in Mechanical Engineering from the Indian Institute of Technology (1967), a MS degree in Operations Research from Cornell University (1969) and a MBA in Finance from Drexel University (1972). Mr. Gupta is a past Chairman of the American Chemistry Council and the Society of Chemical Industry, America Section. He is a member of the boards of Arconic Inc., IRI and is Chairman of Avantor Inc.

Mr. Raj and Mrs. KAMLA Gupta had an arranged marriage in 1968, one week before Raj left for his graduate studies at Cornell University. Mrs. Gupta is one of nine siblings and an accomplished tabla player, very competitive tennis and golf player, and an avid gardener. She has been an incredible partner to Mr. Gupta for over fifty years and an amazing mother to their two daughters, Amita and Vanita. She has made great sacrifices to support the family over the years, adapting to living in England, France and the United States, as well as frequently traveling around the globe. Recently, Mr. and Mrs. Gupta celebrated their 50th anniversary with extended family in India.


The UJALA FOUNDATION was created in 2009 following Mr. Gupta’s retirement from Rohm and Haas Company. The Foundation’s mission is based on the strong convictions of Mr. and Mrs. Gupta that good health and education truly make a difference in achieving one’s full potential. Over the last decade, The Ujala Foundation (in partnership with the Haas family on several ventures) has contributed nearly $15 million to institutions both in India and the United States. Johns Hopkins remains the biggest beneficiary followed by Drexel and Cornell Universities, the Philadelphia Zoo, the Philadelphia Museum of Art, Pratham, Ekal Vidialaya, the America India Foundation, Indiaspora and many others. Mr. and Mrs. Gupta hope to expand the scope of The Ujala Foundation in the years ahead.

Held by Robert C. Bollinger

Dr. ROBERT BOLLINGER is Founding Director of the Center for Clinical Global Health Education (CCGHE) and Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine. He holds joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. He is Associate Director for Medicine of the JH Center for Global Health, Director of the JHU Fogarty India Program. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases.

Dr. Bollinger has more than 39 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections and other emerging diseases. His research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; development/evaluation of novel point-of-care diagnostics and implementation science research projects to optimize healthcare capacity and delivery in resource-limited settings. Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and the award-winning emocha mobile health platform. He has been invited to participate in public health training programs and expert committees, in more than 15 countries. He served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), a member of the PACHA International Sub-committee, and a member of the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety. He also currently serves as a member of the NIH Fogarty International Center Advisory Board.

Dr. Bollinger is committed to improving the health of people living in resource-limited communities through clinical research, education, and leadership training. He established health research and education programs in countries throughout Africa, South and Central America, Southeast Asia, and the Middle East. In 1991, he initiated an NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Government Medical College. He has served as Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which changed World Health Organization (WHO) guidelines for treatment of infants born to HIV/positive mothers to prevent mother-to-child transmission. Under his 26 years as leader of the Hopkins India Fogarty International Research Training Program, short-term and degree training has been provided to more than 140 visiting Indian scientists at JHU, and in-country training has been provided to more than 2000 Indian scientists. His commitment to education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award.

Dr. Bollinger is author of more than 190 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision.

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Master of Public Health from JH Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at JHU School of Medicine.